Get started
HIMS & HERS HEALTH INCHIMS & HERS HEALTH INCHIMS & HERS HEALTH INC

HIMS & HERS HEALTH INC

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

HIMS trade ideas

Is it a time for HIMS? Potential 50%,target 75USD.The company has announced plans to introduce comprehensive at-home lab tests, leveraging the acquisition of Trybe Labs, which could enhance service personalization and attract new customers. Additionally, expansion into markets such as Canada and Europe (through the acquisition of Zava) opens new revenue growth opportunities. The company demonstrates continuous financial improvement, including record profitability and a 111% revenue increase since reaching its ATH (All-Time High) in February 2025, which builds investor confidence. The chart analysis of Hims & Hers Health, Inc. (NYSE: HIMS) indicates a clear upward trend in the recent period. The current price is approximately 49.38 USD. Based on historical data and visible momentum, there is potential for a growth of about 50%, which could bring the price to around 75 USD. Key support is located around 45 USD, while resistance may be tested in the 55-60 USD range before further upward movement. It is recommended to monitor volume and key technical levels to confirm the continuation of the trend. Potential TP: 75 $
NYSE:HIMSLong
by darksignal
1
My buy view for Hims & Hers stock. My buy view for Hims & Hers stock. Overall, I believe this asset is still in a bullish direction. I remember hoping into accummulating this stock when it dropped from $64 to $41 at the open of market on 23/6/2025 which I sold off when it hit $50. However, I still hold a strong buy bias with my entry and exit showing on my chart (analysis). Please trade with care as I still look forward to $64 per share for this stock long-term. Please, kindly like, share your thoughts via comment and follow me for more.
NYSE:HIMSLong
by ForexClinik
HIMS WEEKLY BULLISH PLAY — 07/23/2025 🩺 HIMS WEEKLY BULLISH PLAY — 07/23/2025 📈 Momentum Up, Flow Bullish, Time Tight — Let’s Ride It ⸻ 🔍 MARKET SNAPSHOT 5-model AI consensus = ✅ BULLISH Why? • 📈 Weekly RSI = 58.2 (Rising) — Clear momentum • ⚖️ Call/Put Ratio = 1.63 — Big call volume (45K+) • 📉 Volume = 0.9x — ⚠️ Slight institutional hesitation • 🌪️ VIX = 16.0 — Low volatility = smoother execution ⸻ 🎯 TRADE IDEA — CALL OPTION PLAY { "instrument": "HIMS", "direction": "CALL", "strike": 58.00, "entry_price": 0.86, "profit_target": 1.72, "stop_loss": 0.43, "expiry": "2025-07-25", "confidence": 75%, "entry_timing": "Open", "size": 1 contract } ⸻ 📊 TRADE PLAN 🔹 🔸 🎯 Strike 58 CALL 💵 Entry 0.86 🎯 Profit Target 1.72 (+100%) 🛑 Stop Loss 0.43 (tight risk) 📅 Expiry July 25 (2DTE) ⚡ Confidence 75% 📈 Size Suggestion Risk 2–3% of capital ⚠️ Key Risks Low volume + high gamma exposure ⸻ 🧠 MODEL TAKEAWAYS ✅ RSI and momentum are clearly aligned upward ✅ Call flow = bullish commitment ⚠️ Volume is light → watch for momentum stalls ⚠️ Gamma risk = manage tight, exit fast ⸻ 💬 Drop a 🧠 if you’re tracking 📈 Drop a 💥 if you’re in this call 🛎️ Trade tight — expiration Friday, HIMS is moving on momentum not mass #HIMS #OptionsTrading #CallOptions #BullishPlay #MomentumTrade #ZeroDTE #GammaScalp #AITrading #HealthcareStocks
NYSE:HIMSLong
by quantsignals
Neowave Structural Outlook – Complex Correction: W–X–Y–X–ZThis analysis interprets the ongoing structure as a Complex Correction in the form of a W–X–Y–X–Z pattern. Here's a breakdown of the logic behind the wave labeling and key observations: Overall Structural Summary: W wave (M1–M5): Though M1 is labeled as ":5", a closer examination of its internal structure reveals corrective characteristics. Therefore, the entire M1–M5 segment is best interpreted as a complex corrective structure, possibly a double three or flat. X wave 1 (M6–M8): A clear Zigzag, fulfilling the requirements for a valid X. All relevant time and price criteria are met, forming a neat connector after W. Y wave (M9–M13): M9–M10: A Zigzag formation. M11–M12–M13: M12 serves as an x-wave, and M13 unfolds as a simple corrective move in three waves, completing the Y wave. Though M13 is a single-leg visually, the internal structure confirms a three-part move. The Y wave is longer in both time and complexity, appropriate for its position in the sequence. X wave 2 (M14): Despite appearing as a short single move, it satisfies the X criteria in the context of the ongoing correction. The small size is acceptable as per rule allowances for connectors in Z formations. Z wave (M15–ongoing): M15–M17: Another Zigzag, forming the first leg of Z. M18: Likely the X connector within Z. M19: Assumed to be the beginning of the final leg of Z. The structure from here forward will determine whether Z completes as a triangle, zigzag, or another combination. Supporting Rule Applications: Several Neowave rules were cross-verified: - Rule 2a and 5a were referenced to validate corrections that exceed the 61.8% retracement and duration benchmarks. - Rule 7c and 4 supported impulse invalidations and corrections involving running structures. Time symmetry across connectors and leg duration was considered to maintain wave consistency. Visual Channels: All W, Y, and Z legs are progressing within clearly defined channels. The Z leg is currently within a steep rising channel. If Z completes as a non-triangular formation, a reversal might follow. Conclusion & Risk Notes: This structure, though corrective in nature, contains strong upward segments — especially within Z — making it tradable for bullish swings. Given that Z is the final leg, caution is warranted. Once Z completes (especially if M19 develops into a three-wave structure), the larger correction may terminate, potentially leading to a larger trend reversal. Position management (e.g., scaling out or using stop-losses) is advised as the structure evolves.
NYSE:HIMS
by MagicCrow
HIMS · 4H — Symmetrical Triangle Breakout Targeting $55 → $60Setup Breakdown HIMS is forming a symmetrical triangle consolidation, with price tightening between rising support and descending resistance. The structure follows a previous impulsive move, suggesting this is likely a bullish continuation pattern. Volume is contracting — typical for pre-breakout setups — and price is holding above a key short-term rising trendline. A breakout above $52–53 could initiate a fast move into the next resistance band. --- 🎯 Target Zone 🎯 Target Level Reason Target-1 $55.50 (38.2% Fib) Volume gap fill + first resistance from prior consolidation range. A clean spot for partial profits. Target-2 $60.00 (50% Fib) Strong historical resistance + Fibonacci confluence. Ideal level to take the rest of the position or trail a runner. --- 🛠️ Trade Plan (Example) Component Action Trigger Long on a confirmed breakout above $52 with volume ≥ 20-SMA Entry Add-on Pullback retest of broken triangle resistance ($52) acting as new support Stop-loss Close < $49.50 — invalidates the triangle TP-1 $55.50 — take 50–70% off, move stop to breakeven TP-2 $60.00 — exit or leave a small runner in case of further breakout --- ⚠️ Risk Notes Earnings date approaching – trade may need to be closed or hedged before volatility spikes. Break below $49.50 invalidates the pattern and opens risk to $46 or lower. Watch for volume confirmation — fakeouts can occur if breakout lacks momentum. --- ✅ Checklist Triangle structure with strong trendline support Low-volume zone between $53–60 favors fast expansion Targets align with Fib + volume profile Risk clearly defined Earnings awareness in place > Disclaimer: This is not financial advice. Trade your own plan and manage risk appropriately.
NYSE:HIMSLong
by VarghaVafa
$HIMS | Cup & Handle Setup FormingA classic cup & handle setup is building on the 4H chart. Price just broke out of a falling channel (handle), and is now testing a key breakout zone between $48–$53. A daily close above $54–$55 with volume would confirm continuation. I’ve mapped out three potential price targets ($73.88, $99.17, $145.34) based on the depth of the cup and Fibonacci extensions. Watching: RSI trending higher Bullish trend intact via 8/21 EMA Sub-$40 = pattern invalidation Breakout + volume = go time. Watching closely this week.
NYSE:HIMSLong
by Lum3n
HIMS - Potential Bearish ABCD & FVG Retest Setup (4H)\HIMS is currently showing signs of a potential bearish ABCD pattern forming, with the recent rejection at point A and retracement towards B, holding around the 1.617 Fibonacci extension level. A possible short-term bounce may occur toward point C (0.618 retracement), before continuing downward. 📉 Bearish Scenario: If C confirms as a lower high, a drop toward the FVG GAP zone between $31.85 and $27.94 becomes highly probable, aligning with the 1.618–1.886 Fib extension. The volume profile indicates a low-volume node (LVN) around the FVG, making it an attractive magnet for price. 🔍 Key Levels: Resistance Zone (Red Box): $66–$74 (previous supply and high-volume node) Support/FVG Target: $31.85 (1.618 ext) / $27.94 (1.886 ext) POC above: $56.02 – potential pivot level if bulls regain control ⚠️ Watch for: Reaction at $49.50–$50.00 resistance (0.618 retrace zone) Volume confirmation on breakdown toward FVG zone
NYSE:HIMSShort
by msezng
6/25/25 - $hims - How I'm trading this for size6/25/25 :: VROCKSTAR :: NYSE:HIMS How I'm trading this for size - i make a lot of moves, as you can tell. but you'll also notice i tend to find positions that i like as i validate the thesis... and go massive - NYSE:HIMS and NASDAQ:TSLA are two names that i'm not new to, but have been wrangling for some time given valuations really haven't been "cheap" per se. there's a good reason for that. - so $hims. i reset book last night, and now after seeing this thing to red on the day after opening to a squeeze nearly >5%... i'm back to wranging. i. want. to. own. this. it's scarce paper. a scarce CEO. scarce growth. and it's hitting right at the heart of the war on pharma, in it's own "novel" way that just makes me excited to root for the success. - valuation is not honestly, expensive - but communication and headlines will drive a lot of price action (as has been the case) now that NVO has unofficially announced that they're losing market share and, frankly, the stock is uninvestable and will ultimately underperform the winner NYSE:HIMS - SO - I'd like to make this a 5...10...15% size should oppty allow for it. - but LEAPS are expensive. I also have my eye on more of a retrace toward mid 30s if we get a garden variety pullback in general risk (go read my S&P issue from last night... i still think we r trucking higher, but am prepared for this garden variety pullback as well). SHOULD THIS HAPPEN, NYSE:HIMS would be a name that probably eats more beta dirt than others given the recent action (i'm thinking from a big money institutional ownership perspective). - therefore, i'm playing bi weekly ITM calls for size but in a paradoxical way, hoping i lose money on these... so i can grow the duration of my exposure and at a lower strike. - for now i like the bi weekly $40s ... i'd like to extend this to monthlies should we go lower at a lower strike... and if we do see mid 30s (and i'll be writing about this name if that happens!) i'd attempt to LEAP it out for some big size. keep me posted if u see anything worth flagging on the name V
NYSE:HIMSLong
by VROCKSTAR
2
Safe Entry Zone HIMS Part-2After the 150%+ profit reached. in part-0 Stock reached blue zone which was part-1 analysis target. Now Target Reached. Despite the termination of Novo drugs with HIMs which will hurt HIMS on long run for sure unless they figure out something. I strongly believe despite negativity and all bad news price subjected to 55%+ run to Red Zone. STOP LOSS is below Blue Zone. MUST BE. Price is Volatile at current price level due to Buyers and Sellers Fighting. which is fine. Note: 1- Potentional of Strong Buying Zone: We have two scenarios must happen at The Mentioned Zone: Scenarios One: strong buying volume with reversal Candle. Scenarios Two: Fake Break-Out of The Buying Zone. Both indicate buyers stepping in strongly. NEVER Join in unless one showed up. 2- How to Buy Stock: On 15M TF when Marubozu Candle show up which indicate strong buyers stepping-in. Buy on 0.5 Fibo Level of the Marubozu Candle, because price will always and always re-test the imbalance.
NYSE:HIMSLong
by Faisalzor
HIMS – Long Setup | Potential 60% MoveHims & Hers (HIMS) just gave us a textbook Ichimoku breakout and is holding strong above the cloud after a healthy pullback. Technical Breakdown: Price above Kumo Cloud: Bullish structure intact. Support held at $54.62 – key base above cloud and Tenkan-sen. MACD is curling back after a corrective wave, showing early signs of momentum returning. Risk/Reward: 8.59 – Extremely favorable. Target: $93.58 (60.22% upside) Stop: $51.78 (7.01% downside) Rationale: HIMS continues to ride bullish sentiment in the healthcare and telemedicine sectors. This chart has a clean continuation setup with institutional buy zones likely around $54-$55. Risk is tightly controlled, and upside potential is significant.
NYSE:HIMSLong
by tothemoon_888
1
HIMS 1D — This pattern didn’t cook for nothingOn the daily chart of Hims & Hers Health, we’re looking at a textbook cup with handle formation — not just a pattern, but a structure backed by time, volume, and classic price behavior. The base of the cup formed steadily from February to May 2025, and as soon as the curve was complete, price transitioned into a tight consolidation — the "handle" that often masks real accumulation. Right now, price is testing the resistance area. And it’s not just floating up there — it’s coming in hot: price has already broken through EMA 20/50/100/200 and SMA 50/200. That’s a full stack flip. This isn’t sideways noise — it’s a structural shift in control. Volume is starting to build as price rises, confirming that demand is real and institutional positioning likely active. We’re watching a breakout zone above the handle — and when that breaks, the structure unlocks with a clear target: $107.25, roughly a 2x move from current levels. This setup isn’t noise. It’s a long-cooked formation that’s now about to boil over. If the handle holds and price breaks through — the rest is just follow-through.
NYSE:HIMSLong
by TotoshkaTrades
12
HIMS puked up its Wegovy today!Hims & Hers Health HIMS shares were down more than 34.63% in Monday trading, while Novo Nordisk NVO stock was down over 5% after Novo Nordisk said it has halted its collaboration with Hims & Hers on the sale of weight loss drugs, including Wegovy. The two companies launched a collaboration in April to bundle Wegovy through Hims & Hers' telehealth platform. Novo Nordisk said direct access to the drug would no longer be available through Hims & Hers Health because the company "has failed to adhere to the law which prohibits mass sales of compounded drugs under the false guise of 'personalization' and are disseminating deceptive marketing that put patient safety at risk." This stock failed to catch a bid despite the equity markets strong.
NYSE:HIMS
by Trading-Capital
3
6/23/25 - $hims - Time to re-accumulate6/23/25 :: VROCKSTAR :: NYSE:HIMS Time to re-accumulate - NYSE:NVO are playing dirty and this is a tell and low-key admission that NYSE:HIMS holds all the power - distribution is key... look at NASDAQ:META , NASDAQ:AAPL , $AMZN. he who holds the customer relationship makes the rules - there is no longer a major advantage in developing pharma, the majority of solutions can now roll off patents and/or be compounded *legally* - so what you're seeing here is cartel-like behavior from a slow motion train wreck NYSE:NVO - which i've liked the past - but ultimately the stock will lose to names like NYSE:HIMS (and other pharma too). - so will they get sued? who tf cares. we'll buy more - this is a rule of 40 winner, even if law suit is large, it won't affect the story and growth. and major kudos to Andrew (the rockstar CEO) that put out this tweet. this is a founder-leader you want to put your portfolio behind when the opportunities arise. i'll be looking for oppty in the coming days/weeks to own more of this and would consider making it a decent size LT position at the right valuation, perhaps if we get back into the mid 30s. but i'm not holding my breath. this stock is scarce paper. and you know what happens to scarce paper in a USD ponzi scheme that is unwinding day by day by day. Andrew's post: x.com V
NYSE:HIMSLong
by VROCKSTAR
6
Safe Entry Zone HIMSAfter reaching the Target with 150% profit. Now the Blue Zone IC Zone(Interesting Zone or Institutional Candles Zone) is most appealing support level where we wait for Potentional of Strong Buyers to Step In. Note: Potentional of Strong Buying Zone: We have two scenarios must happen at The Mentioned Zone: Scenarios One: strong buying volume with reversal Candle. Scenarios Two: Fake Break-Out of The Buying Zone. Both indicate buyers stepping in strongly. NEVER Join in unless one showed up. Take Care.
NYSE:HIMS
by Faisalzor